Citations (50)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Jean-Louis Excler & Jerome H. Kim. (2019) Novel prime-boost vaccine strategies against HIV-1. Expert Review of Vaccines 18:8, pages 765-779.
Read now
Read now
Catherine J Luke & Kanta Subbarao. (2014) Improving pandemic H5N1 influenza vaccines by combining different vaccine platforms. Expert Review of Vaccines 13:7, pages 873-883.
Read now
Read now
Simone C de Cassan & Simon J Draper. (2013) Recent advances in antibody-inducing poxviral and adenoviral vectored vaccine delivery platforms for difficult disease targets. Expert Review of Vaccines 12:4, pages 365-378.
Read now
Read now
Sorachai Nitayaphan, Viseth Ngauy, Robert O’Connell & Jean-Louis Excler. (2012) HIV epidemic in Asia: optimizing and expanding vaccine development. Expert Review of Vaccines 11:7, pages 805-819.
Read now
Read now
Articles from other publishers (46)
Julia Rühl, Carol S. Leung & Christian Münz. (2020) Vaccination against the Epstein–Barr virus. Cellular and Molecular Life Sciences 77:21, pages 4315-4324.
Crossref
Crossref
Tayebeh Rezaei, Saeed Khalili, Behzad Baradaran, Jafar Mosafer, Sarah Rezaei, Ahad Mokhtarzadeh & Miguel de la Guardia. (2019) Recent advances on HIV DNA vaccines development: Stepwise improvements to clinical trials. Journal of Controlled Release 316, pages 116-137.
Crossref
Crossref
Sivasankaran Munusamy Ponnan, Sathyamurthy Pattabiram, Kannan Thiruvengadam, Rajat Goyal, Nikhil Singla, Joyeeta Mukherjee, Shweta Chatrath, Philip Bergin, Jakub T. Kopycinski, Jill Gilmour, Sriram Kumar, Malathy Muthu, Sudha Subramaniam, Soumya Swaminathan, Srikanth Prasad Tripathy & Hanna Elizabeth Luke. (2019) Induction and maintenance of bi-functional (IFN-γ + IL-2+ and IL-2+ TNF-α+) T cell responses by DNA prime MVA boosted subtype C prophylactic vaccine tested in a Phase I trial in India. PLOS ONE 14:3, pages e0213911.
Crossref
Crossref
Gabriel Byrne, Sara M. O’Rourke, David L. Alexander, Bin Yu, Rachel C. Doran, Meredith Wright, Qiushi Chen, Parastoo Azadi & Phillip W. Berman. (2018) CRISPR/Cas9 gene editing for the creation of an MGAT1-deficient CHO cell line to control HIV-1 vaccine glycosylation. PLOS Biology 16:8, pages e2005817.
Crossref
Crossref
Wan Liu, Yik Chun Wong, Samantha M.Y. Chen, Jiansong Tang, Haibo Wang, Allen Ka Loon Cheung & Zhiwei Chen. (2018) DNA prime/MVTT boost regimen with HIV-1 mosaic Gag enhances the potency of antigen-specific immune responses. Vaccine 36:31, pages 4621-4632.
Crossref
Crossref
Edmund G. Wee, Beatrice Ondondo, Peter Berglund, Jacob Archer, Andrew J. McMichael, David Baltimore, Jan H. ter Meulen & Tomáš Hanke. (2017) HIV-1 Conserved Mosaics Delivered by Regimens with Integration-Deficient DC-Targeting Lentiviral Vector Induce Robust T Cells. Molecular Therapy 25:2, pages 494-503.
Crossref
Crossref
Michelle C. Crank, Eleanor M. P. Wilson, Laura Novik, Mary E. Enama, Cynthia S. Hendel, Wenjuan Gu, Martha C. Nason, Robert T. Bailer, Gary J. Nabel, Adrian B. McDermott, John R. Mascola, Richard A. Koup, Julie E. Ledgerwood & Barney S. Graham. (2016) Safety and Immunogenicity of a rAd35-EnvA Prototype HIV-1 Vaccine in Combination with rAd5-EnvA in Healthy Adults (VRC 012). PLOS ONE 11:11, pages e0166393.
Crossref
Crossref
Stephen R. Walsh, Zoe Moodie, Andrew J. Fiore-Gartland, Cecilia Morgan, Marissa B. Wilck, Scott M. Hammer, Susan P. Buchbinder, Spyros A. Kalams, Paul A. Goepfert, Mark J. Mulligan, Michael C. Keefer, Lindsey R. Baden, Edith M. Swann, Shannon Grant, Hasan Ahmed, Fusheng Li, Tomer Hertz, Steven G. Self, David Friedrich, Nicole Frahm, Hua-Xin Liao, David C. Montefiori, Georgia D. Tomaras, M. Juliana McElrath, John Hural, Barney S. Graham & Xia Jin. (2016) Vaccination With Heterologous HIV-1 Envelope Sequences and Heterologous Adenovirus Vectors Increases T-Cell Responses to Conserved Regions: HVTN 083. Journal of Infectious Diseases 213:4, pages 541-550.
Crossref
Crossref
Ronald A Brooks, Raphael J Landovitz, Rotrease Regan, Sung-Jae Lee & Vincent C AllenJrJr. (2015) Perceptions of and intentions to adopt HIV pre-exposure prophylaxis among black men who have sex with men in Los Angeles. International Journal of STD & AIDS 26:14, pages 1040-1048.
Crossref
Crossref
Annalisa Ciabattini, Gennaro Prota, Dennis Christensen, Peter Andersen, Gianni Pozzi & Donata Medaglini. (2015) Characterization of the Antigen-Specific CD4+ T Cell Response Induced by Prime-Boost Strategies with CAF01 and CpG Adjuvants Administered by the Intranasal and Subcutaneous Routes. Frontiers in Immunology 6.
Crossref
Crossref
Maria L. Knudsen, Karl Ljungberg, Roger Tatoud, Jonathan Weber, Mariano Esteban & Peter Liljeström. (2015) Alphavirus Replicon DNA Expressing HIV Antigens Is an Excellent Prime for Boosting with Recombinant Modified Vaccinia Ankara (MVA) or with HIV gp140 Protein Antigen. PLOS ONE 10:2, pages e0117042.
Crossref
Crossref
Babs E Verstrepen. (2015) Immune mechanisms of vaccine induced protection against chronic hepatitis C virus infection in chimpanzees. World Journal of Hepatology 7:1, pages 53.
Crossref
Crossref
Shailbala Singh, Guojun Yang, Siddappa N. Byrareddy, Michael A. Barry & K. Jagannadha Sastry. (2014) Natural killer T cell and TLR9 agonists as mucosal adjuvants for sublingual vaccination with clade C HIV-1 envelope protein. Vaccine 32:51, pages 6934-6940.
Crossref
Crossref
Paul A. Goepfert, Marnie L. Elizaga, Kelly Seaton, Georgia D. Tomaras, David C. Montefiori, Alicia Sato, John Hural, Stephen C. DeRosa, Spyros A. Kalams, M. Juliana McElrath, Michael C. Keefer, Lindsey R. Baden, Javier R. Lama, Jorge Sanchez, Mark J. Mulligan, Susan P. Buchbinder, Scott M. Hammer, Beryl A. Koblin, Michael Pensiero, Chris Butler, Bernard Moss & Harriet L. Robinson. (2014) Specificity and 6-Month Durability of Immune Responses Induced by DNA and Recombinant Modified Vaccinia Ankara Vaccines Expressing HIV-1 Virus-Like Particles. The Journal of Infectious Diseases 210:1, pages 99-110.
Crossref
Crossref
Zhidong Hu, Jing Wang, Yanmin Wan, Lingyan Zhu, Xiaonan Ren, Sugan Qiu, Yanqin Ren, Songhua Yuan, Xiangqing Ding, Jian Chen, Chenli Qiu, Jun Sun, Xiaoyan Zhang, Jim Xiang, Chao Qiu & Jianqing Xu. (2014)
Boosting Functional Avidity of CD8
+
T Cells by Vaccinia Virus Vaccination Depends on Intrinsic T-Cell MyD88 Expression but Not the Inflammatory Milieu
. Journal of Virology 88:10, pages 5356-5368.
Crossref
Crossref
Robert Paris, Robert A. Kuschner, Leonard Binn, Stephen J. Thomas, Stefano Colloca, Alfredo Nicosia, Riccardo Cortese, Robert T. Bailer, Nancy Sullivan & Richard A. Koup. (2014) Adenovirus Type 4 and 7 Vaccination or Adenovirus Type 4 Respiratory Infection Elicits Minimal Cross-Reactive Antibody Responses to Nonhuman Adenovirus Vaccine Vectors. Clinical and Vaccine Immunology 21:5, pages 783-786.
Crossref
Crossref
Thomas Grunwald, Matthias Tenbusch, Reiner Schulte, Katharina Raue, Hans Wolf, Drew Hannaman, Rik L. de Swart, Klaus Überla & Christiane Stahl-Hennig. (2014) Novel Vaccine Regimen Elicits Strong Airway Immune Responses and Control of Respiratory Syncytial Virus in Nonhuman Primates. Journal of Virology 88:8, pages 3997-4007.
Crossref
Crossref
Edward S. Mocarski, William J. Kaiser, Devon Livingston-Rosanoff, Jason W. Upton & Lisa P. Daley-Bauer. (2014) True Grit: Programmed Necrosis in Antiviral Host Defense, Inflammation, and Immunogenicity. The Journal of Immunology 192:5, pages 2019-2026.
Crossref
Crossref
Markus Vähä-Koskela, Siri Tähtinen, Susanna Grönberg-Vähä-Koskela, Kristian Taipale, Dipongkor Saha, Maiju Merisalo-Soikkeli, Marko Ahonen, Noora Rouvinen-Lagerström, Mari Hirvinen, Ville Veckman, Sampsa Matikainen, Fang Zhao, Päivi Pakarinen, Jarmo Salo, Anna Kanerva, Vincenzo Cerullo & Akseli Hemminki. (2014) Overcoming tumor resistance by heterologous adeno-poxvirus combination therapy. Molecular Therapy - Oncolytics 1, pages 14006.
Crossref
Crossref
Jean-Louis Excler, Georgia D. Tomaras & Nina D. Russell. (2013) Novel directions in HIV-1 vaccines revealed from clinical trials. Current Opinion in HIV and AIDS 8:5, pages 421-431.
Crossref
Crossref
Aurélie Girard, Élodie Roques, Marie-Claude St-Louis, Bernard Massie & Denis Archambault. (2013) Expression of Human Rotavirus Chimeric Fusion Proteins from Replicating but Non Disseminating Adenovectors and Elicitation of Rotavirus-Specific Immune Responses in Mice. Molecular Biotechnology 54:3, pages 1010-1020.
Crossref
Crossref
Karina Furmanov, Mazal Elnekave, Abdallah Sa'eed, Hadas Segev, Luba Eli-Berchoer, Darrell N. Kotton, Gilad Bachrach & Avi-Hai Hovav. (2013) Diminished Memory T-Cell Expansion Due to Delayed Kinetics of Antigen Expression by Lentivectors. PLoS ONE 8:6, pages e66488.
Crossref
Crossref
Sten H. Vermund, José A. Tique, Holly M. Cassell, Megan E. Pask, Philip J. Ciampa & Carolyn M. Audet. (2013) Translation of Biomedical Prevention Strategies for HIV. JAIDS Journal of Acquired Immune Deficiency Syndromes 63:Supplement 1, pages S12-S25.
Crossref
Crossref
Érica Araújo Mendes, Flavio G. Fonseca, Bárbara M. Casério, Janaína P. Colina, Ricardo Tostes Gazzinelli & Braulia C. Caetano. (2013) Recombinant Vaccines against T. gondii: Comparison between Homologous and Heterologous Vaccination Protocols Using Two Viral Vectors Expressing SAG1. PLoS ONE 8:5, pages e63201.
Crossref
Crossref
M Jeyanathan, D Damjanovic, C R Shaler, R Lai, M Wortzman, C Yin, A Zganiacz, B D Lichty & Z Xing. (2013) Differentially imprinted innate immunity by mucosal boost vaccination determines antituberculosis immune protective outcomes, independent of T-cell immunity. Mucosal Immunology 6:3, pages 612-625.
Crossref
Crossref
Monica Vaccari, Rabih Halwani, L. Jean Patterson, Adriano Boasso, Jennifer Beal, Elzbieta Tryniszewska, Anna Hryniewicz, David Venzon, Elias K. Haddad, Mohamed El-Far, Margherita Rosati, George N. Pavlakis, Barbara K. Felber, Saleh Al-Muhsen, Marjorie Robert-Guroff, Rafick-Pierre Sekaly & Genoveffa Franchini. (2013)
Antibodies to gp120 and PD-1 Expression on Virus-Specific CD8
+
T Cells in Protection from Simian AIDS
. Journal of Virology 87:6, pages 3526-3537.
Crossref
Crossref
Stephen R. Walsh, Michael S. Seaman, Lauren E. Grandpre, Cherie Charbonneau, Katherine E. Yanosick, Barbara Metch, Michael C. Keefer, Raphael Dolin & Lindsey R. Baden. (2012) Impact of anti-orthopoxvirus neutralizing antibodies induced by a heterologous prime-boost HIV-1 vaccine on insert-specific immune responses. Vaccine 31:1, pages 114-119.
Crossref
Crossref
Katherine A. Richards, Francisco A. Chaves, Shabnam Alam & Andrea J. Sant. (2012) Trivalent inactivated influenza vaccines induce broad immunological reactivity to both internal virion components and influenza surface proteins. Vaccine 31:1, pages 219-225.
Crossref
Crossref
Kevin O. Saunders, Rebecca S. Rudicell & Gary J. Nabel. (2012) The design and evaluation of HIV-1 vaccines. AIDS 26:10, pages 1293-1302.
Crossref
Crossref
Takuya Osada, Michael A. Morse, Amy Hobeika & H. Kim Lyerly. (2012) Novel Recombinant Alphaviral and Adenoviral Vectors for Cancer Immunotherapy. Seminars in Oncology 39:3, pages 305-310.
Crossref
Crossref
Mark S. de Souza, Silvia Ratto-Kim, Weerawan Chuenarom, Alexandra Schuetz, Somsak Chantakulkij, Bessara Nuntapinit, Anais Valencia-Micolta, Doris Thelian, Sorachai Nitayaphan, Punnee Pitisuttithum, Robert M. Paris, Jaranit Kaewkungwal, Nelson L. Michael, Supachai Rerks-Ngarm, Bonnie Mathieson, Mary Marovich, Jeffrey R. Currier, Jerome H. Kim, Supachai Rerks-Ngarm, Supamit Chunsuttiwat, Nakorn Premsri, Chawetsan Namwat, Prayura Kunasol, Prasert Thongcharoen, Chirasak Khamboonruang, Punnee Pitisuttithum, Valai Bussaratid, Wirach Maek-a-nantawat, Jittima Dhitavat, Pravan Suntharasamai, Swangjai Pungpak, Siriwan Vanijanonta, Jaranit Kaewkunwal, Amnat Khamsiriwatchara, Pawinee Jarujareet, Sorachai Nitayaphan, Chirapa Easmila, Suchana Tabprasit, Viseth Ngauy, Robert Paris, Michael Benenson, Patricia Morgan, Weerawan Chuenarom, Arthur Brown, Mark de Souza, Rapee Trichavaroj, Alexandra Schuetz, Nusara Thaitawat, Bessara Nuntapinit, Kanyasiri Kongnonkok, Boot Keawboon, Yuwadee Phuang-Ngern, Susan Mason, Sanjay Gurunathan, Jim Tartaglia, John G. McNeil, Robin Harkness, Claude Meric, Lynn Baglyos, Raphaelle El Habib, Don Francis, Carter Lee, Elizabeth Adams, Jerome H. Kim, Merlin L. Robb, Nelson L. Michael, Mark Milazzo, Amy Bolen, Beryl Wessner, Silvia Ratto-Kim, Mary Marovich, Jeffrey Currier, Deborah L. Birx, Don Stablein, Terry Germanson, Len Dally, Jean-Louis Excler & Jeffrey Berenberg. (2012) The Thai Phase III Trial (RV144) Vaccine Regimen Induces T Cell Responses That Preferentially Target Epitopes within the V2 Region of HIV-1 Envelope. The Journal of Immunology 188:10, pages 5166-5176.
Crossref
Crossref
Maria L. Knudsen, Alice Mbewe-Mvula, Maximillian Rosario, Daniel X. Johansson, Maria Kakoulidou, Anne Bridgeman, Arturo Reyes-Sandoval, Alfredo Nicosia, Karl Ljungberg, Tomáš Hanke & Peter Liljeström. (2012) Superior Induction of T Cell Responses to Conserved HIV-1 Regions by Electroporated Alphavirus Replicon DNA Compared to That with Conventional Plasmid DNA Vaccine. Journal of Virology 86:8, pages 4082-4090.
Crossref
Crossref
Sarah Kutscher, Tanja Bauer, Claudia Dembek, Martin Sprinzl & Ulrike Protzer. (2012) Design of therapeutic vaccines: hepatitis B as an example. Microbial Biotechnology 5:2, pages 270-282.
Crossref
Crossref
Chang Li, Zhenwei Shen, Xiao Li, Jieying Bai, Lin Zeng, Mingyao Tian, Ying Jin Song, Ming Ye, Shouwen Du, Dayong Ren, Cunxia Liu, Na Zhu, Dandan Sun, Yi Li & Ningyi Jin. (2012) Protection against SHIV-KB9 Infection by Combining rDNA and rFPV Vaccines Based on HIV Multiepitope and p24 Protein in Chinese Rhesus Macaques. Clinical and Developmental Immunology 2012, pages 1-9.
Crossref
Crossref
Tyler H.T. Brown, Jason David, Elizabeth Acosta-Ramirez, Jessica M. Moore, Song Lee, Guangming Zhong, Robert E.W. Hancock, Zhou Xing, Scott A. Halperin & Jun Wang. (2012) Comparison of immune responses and protective efficacy of intranasal prime-boost immunization regimens using adenovirus-based and CpG/HH2 adjuvanted-subunit vaccines against genital Chlamydia muridarum infection. Vaccine 30:2, pages 350-360.
Crossref
Crossref
Pedro Romero & Daniel E. Speiser. 2012. Targeted Therapeutics in Melanoma. Targeted Therapeutics in Melanoma
207
232
.
Punnee Pitisuttithum, Supachai Rerks-Ngarm, Valai Bussaratid, Jittima Dhitavat, Wirach Maekanantawat, Swangjai Pungpak, Pravan Suntharasamai, Sirivan Vanijanonta, Sorachai Nitayapan, Jaranit Kaewkungwal, Michael Benenson, Patricia Morgan, Robert J. O'Connell, Jeffrey Berenberg, Sanjay Gurunathan, Donald P. Francis, Robert Paris, Joseph Chiu, Donald Stablein, Nelson L. Michael, Jean-Louis Excler, Merlin L. Robb & Jerome H. Kim. (2011) Safety and Reactogenicity of Canarypox ALVAC-HIV (vCP1521) and HIV-1 gp120 AIDSVAX B/E Vaccination in an Efficacy Trial in Thailand. PLoS ONE 6:12, pages e27837.
Crossref
Crossref
Jie Guan, Bo Wen, Yao Deng, Ke Zhang, Hong Chen, Xiaobing Wu, Li Ruan & Wenjie Tan. (2011) Effect of route of delivery on heterologous protection against HCV induced by an adenovirus vector carrying HCV structural genes. Virology Journal 8:1.
Crossref
Crossref
Yen-Ju Shen, Enid Shephard, Nicola Douglass, Nicolette Johnston, Craig Adams, Carolyn Williamson & Anna-Lise Williamson. (2011) A novel candidate HIV vaccine vector based on the replication deficient Capripoxvirus, Lumpy skin disease virus (LSDV). Virology Journal 8:1.
Crossref
Crossref
Richard Hopkins, Anne Bridgeman, Charles Bourne, Alice Mbewe‐Mvula, Jerald C. Sadoff, Gerald W. Both, Joan Joseph, John Fulkerson & Tomáš Hanke. (2011)
Optimizing HIV‐1‐specific CD8
+
T‐cell induction by recombinant BCG in prime‐boost regimens with heterologous viral vectors
. European Journal of Immunology 41:12, pages 3542-3552.
Crossref
Crossref
Muhammad Bakari, Said Aboud, Charlotta Nilsson, Joel Francis, Deus Buma, Candida Moshiro, Eric A. Aris, Eligius F. Lyamuya, Mohamed Janabi, Karina Godoy-Ramirez, Agricola Joachim, Victoria R. Polonis, Andreas Bråve, Patricia Earl, Merlin Robb, Mary Marovich, Britta Wahren, Kisali Pallangyo, Gunnel Biberfeld, Fred Mhalu & Eric Sandström. (2011) Broad and potent immune responses to a low dose intradermal HIV-1 DNA boosted with HIV-1 recombinant MVA among healthy adults in Tanzania. Vaccine 29:46, pages 8417-8428.
Crossref
Crossref
Zi-Guo Yuan, Xiu-Xiang Zhang, Rui-Qing Lin, Eskild Petersen, Shenyi He, Miao Yu, Xian-Hui He, Dong-Hui Zhou, Yong He, Hao-Xin Li, Ming Liao & Xing-Quan Zhu. (2011) Protective effect against toxoplasmosis in mice induced by DNA immunization with gene encoding Toxoplasma gondii ROP18. Vaccine 29:38, pages 6614-6619.
Crossref
Crossref
Benson C. IwerieborPascal O. BessongLufuno G. MavhanduTracy M. MasebeJulius NwobegahaySylvester R. MoyoJeffrey M. Mphahlele. (2011) Genetic Analysis of the Near Full-Length Genome of an HIV Type 1 A1/C Unique Recombinant Form from Northern South Africa. AIDS Research and Human Retroviruses 27:8, pages 911-915.
Crossref
Crossref
Gargi Dasgupta & Lbachir BenMohamed. (2011) Of mice and not humans: How reliable are animal models for evaluation of herpes CD8+-T cell-epitopes-based immunotherapeutic vaccine candidates?. Vaccine 29:35, pages 5824-5836.
Crossref
Crossref
Barbara J. FlynnKathrin KastenmüllerUlrike Wille-ReeceGeorgia D. TomarasMunir AlamRoss W. LindsayAndres M. SalazarBeatriz PerdigueroCarmen E. GomezRalf WagnerMariano EstebanChae G. ParkChristine TrumpfhellerTibor KelerGiuseppe Pantaleo, Ralph M. SteinmanRobert Seder. (2011) Immunization with HIV Gag targeted to dendritic cells followed by recombinant New York vaccinia virus induces robust T-cell immunity in nonhuman primates. Proceedings of the National Academy of Sciences 108:17, pages 7131-7136.
Crossref
Crossref
Junu A. GeorgeSeong Kug Eo. (2011) Distinct Humoral and Cellular Immunity Induced by Alternating Prime-boost Vaccination Using Plasmid DNA and Live Viral Vector Vaccines Expressing the E Protein of Dengue Virus Type 2. Immune Network 11:5, pages 268.
Crossref
Crossref